Tune in to learn how QuartzBio’s Precision Medicine agentic framework, powered by proactive and prescriptive AI, is shortening trial timelines, improving regulatory adherence, and driving operational excellence across the R&D value chain. Our Sample Intelligence AI Agents monitor samples, detect emerging issues, automatically flag root causes, and deliver actionable, corrective guidance.
Heading to this year’s Summit for Clinical Operations Executives? If you’re interested in real-time visibility into collection, shipping, inventory, testing, consent, or site/vendor KPIs stop by booth #720 to chat with our AI Virtual Assistant for sample operations. Make sure to catch QuartzBio Co-Founder and Chief Technology Officer Tobias Guennel, Ph.D., at his session: “Operational […]
This week, as part of our v13.0.0 major release, our customers gained access to the expanding QuartzBio Learning Lab – a centralized, easy-to-navigate hub for training, product documentation, and updates.
Read this 1-page info sheet highlighting a case study showing how QuartzBio delivers 10x faster insights, enabling quicker study closures and better data quality — with no added headcount required.
Request our white paper to see our breakdown of the costs associated with achieving and maintaining compliance using traditional processes and point solutions. You’ll also learn how QuartzBio’s platform approach transforms compliance processes, helping customers lower costs immediately, reducing compliance issues and data problems by over 80%.
We are hosting Innovation Summits on the East and West coast this fall where we gather input from Sponsor teams in translational research, biomarker / biospecimen operations, data science, R&D IT, bioinformatics, and others.
Attending the BiotechX USA conference in Philadelphia? It’s the premier conference for R&D teams who understand the impact of digital transformation across the entire precision medicine value chain. Stop by booth #603 to chat with QuartzBio’s Precision Medicine AI Agents. We’ll demonstrate how our AI agents act as secure, personalized virtual assistants, delivering Sample and Biomarker Intelligence Solutions for translational research, informatics, sample/biomarker operations, and IT teams.
Learn more about the release of version 12.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, featuring enhancements to our Sample Intelligence Solution, our Biomarker Intelligence Solution, and improvements to the underlying data management layer. New capabilities include large file support, dynamic analytics, and richer clinical insights.
The new ICH E6(R3) GCP guideline, impacting clinical studies starting 23 July 2025, introduces significantly more detailed requirements around the integrity and governance of data assets and trial records, including biospecimens, their derivatives, and all associated clinical and assay data generated during trials. To help precision medicine teams ensure they meet these new requirements, we have developed this compliance checklist.
This month, we released version 11.0.0 of QuartzBio’s Precision Medicine AI Agent Platform, featuring enhancements to our Sample Intelligence Solution, our Biomarker Intelligence Solution, and performance improvements to our data management layer.
Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.
QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.
© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR
Web Design and Development by RainCastle Communications.